Bayer AG (Germany) Analysis

Bayer Stock Analysis Notes

About 47.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.37. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bayer AG NA has Price/Earnings To Growth (PEG) ratio of 1.32. The entity last dividend was issued on the 2nd of May 2022. Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER AG is traded on Frankfurt Stock Exchange in Germany. For more info on Bayer AG NA please contact Werner Baumann at 49 214 30 1 or go to https://www.bayer.com.

Bayer AG NA Investment Alerts

Bayer Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 56.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bayer AG's market, we take the total number of its shares issued and multiply it by Bayer AG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bayer Profitablity

The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.

Technical Drivers

As of the 2nd of December, Bayer AG shows the Standard Deviation of 2.58, mean deviation of 1.65, and Risk Adjusted Performance of (0.15). Bayer AG NA technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bayer AG NA mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Bayer AG NA is priced correctly, providing market reflects its regular price of 19.42 per share.

Bayer AG NA Price Movement Analysis

Bayer AG Outstanding Bonds

Bayer AG Predictive Daily Indicators

Bayer AG Forecast Models

Bayer AG's time-series forecasting models are one of many Bayer AG's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bayer AG's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bayer AG prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bayer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bayer AG. By using and applying Bayer Stock analysis, traders can create a robust methodology for identifying Bayer entry and exit points for their positions.

When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.